In addition, FoxM1 may play a key role in the pathogenesis and disease progression of ICC via upregulating and activating the c-Myc signaling pathway and facilitating the expression of the MMP-9 and MMP-2 proteins. Here, MMP9 is linked to intrahepatic cholangiocarcinoma.